ADMA FY 2014 Earnings — ADMA Biologics, Inc. Revenue & Financial Results | Market Cap Arena

ADMAADMA Biologics, Inc.

$4B

FY 2014 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$6M+92.8% YoY

Gross Profit

$2M36.7% margin

Operating Income

-$16M-270.8% margin

Net Income

-$17M-284.2% margin

EPS (Diluted)

$-1.81

Cash Flow

Operating Cash Flow

-$15M

Free Cash Flow

-$17M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$27M

Total Liabilities

$21M

Stockholders' Equity

$6M

Cash & Equivalents

$17M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6M	$3M	+92.8%
Gross Profit	$2M	$1M	+108.1%
Operating Income	-$16M	-$15M	-6.5%
Net Income	-$17M	-$16M	-8.3%